Complete Analysis of Assisted Reproduction Process in Georgia: From Examination to Transfer

Article text begins

Reproductive Medicine Department · Patient Education Material

Real Clinic Records from a Reproductive Doctor — A 43-year-old woman, AMH 0.6, FSH 12.8, total antral follicle count of 3 in both ovaries, with two previous failed IVF attempts, came for consultation about the assisted reproduction process in Georgia carrying thick medical reports. This is a typical dilemma for patients with diminished ovarian reserve (DOR): after repeated failures domestically, they look abroad but are completely unfamiliar with the process. This article, from a clinical perspective of reproductive medicine, breaks down the complete path, timeline, key points, and common blind spots of assisted reproduction in Georgia.

I. Six Core Stages of the Assisted Reproduction Process in Georgia

The assisted reproduction process in Georgia shares common logic with other major international destinations within the legal framework and medical standards, but there are stage-specific differences. A complete cycle includes the following stages:

Stage	Core Content	Time Required
Stage One	Preliminary Medical Evaluation and Preparation	Completed domestically, approx. 1–2 weeks (including tests)
Stage Two	Legal Documents, Visa, and Travel Arrangements	2–4 weeks (depending on document processing speed)
Stage Three	Ovulation Induction and Follicle Monitoring	10–14 days (in Georgia)
Stage Four	Egg Retrieval and Embryo Culture	1 day for retrieval, 3–6 days for culture
Stage Five	Embryo Transfer (or Surrogacy Process)	1 day for transfer, followed by luteal phase support
Stage Six	Post-Transfer Management, Pregnancy Test, and Follow-up	Pregnancy test 10–14 days after transfer

From the initial consultation to the completion of the transfer, a full cycle typically takes 4–8 weeks, depending on individual ovarian response, embryo culture plan, whether PGT genetic testing is performed, and the complexity of the surrogacy process.

II. Stage One: Preliminary Medical Evaluation — The Foundation for Starting the Process

Before departing for Georgia, a complete medical evaluation must be completed. This evaluation determines which protocol is suitable for you, how the ovulation induction dosage is set, and whether there are medical issues that need to be addressed in advance.

Required Tests for the Female Partner

Basic Endocrine Tests: AMH, FSH, LH, Estradiol (E2), Progesterone, Testosterone. AMH is the most stable indicator for assessing ovarian reserve, and FSH reflects ovarian function status.
Antral Follicle Count (AFC): Transvaginal ultrasound to monitor the number of antral follicles in both ovaries, combined with AMH to determine ovarian responsiveness.
Infectious Disease Screening: HIV, Hepatitis B, Hepatitis C, Syphilis, TORCH, etc., typically valid for 3–6 months.
Chromosomal Karyotype Analysis: Especially recommended for patients with recurrent miscarriage, multiple IVF failures, or advanced age.
Uterine Cavity Assessment: Hysteroscopy or saline infusion sonography is recommended to rule out endometrial polyps, adhesions, fibroids, and other factors affecting implantation.

Required Tests for the Male Partner

Semen Analysis: Includes density, motility, and morphology. At least 2 tests, with 2–7 days of abstinence.
Sperm DNA Fragmentation Index (DFI): Essential for those with recurrent implantation failure or miscarriage.
Infectious Disease Screening: Same as for the female partner.
Chromosomal Karyotype Analysis: Recommended for patients with severe oligospermia, asthenospermia, or azoospermia.

▎Doctor's Note: Patients with AMH below 0.7 ng/mL, FSH above 12 IU/L, or total AFC less than 5 are classified as poor ovarian responders (POR). These patients need to discuss ovulation induction protocols (such as PPOS, mild stimulation, dual stimulation, etc.) with their reproductive doctor in advance and set realistic expectations for the number of eggs retrieved. Some centers in Georgia have experience with poor responders, but individual variation is significant, and expectations should not be based on "others' success."
        

III. Differences Between Countries: Characteristics of the Process in Georgia

Compared to common overseas assisted reproduction destinations like Ukraine, Greece, and the United States, Georgia has significant differences in the following areas:

Dimension	Georgia	Ukraine	Greece
Surrogacy Laws	Explicitly allows commercial surrogacy, relatively mature legal framework	Allows surrogacy, but legal stability fluctuates	Only allows surrogacy under specific conditions
Egg/Sperm Donation	Legal, with formal egg and sperm banks	Legal, with many options	Legal, but regulations are stricter
PGT Genetic Testing	Available, but laboratory qualifications need verification	Widely available	Widely available
Process for International Patients	Relatively simplified, some centers have Chinese coordinators	Mature process, coordination services common	Standardized process, language support varies by center
Total Cycle Cost (Reference)	Moderately low	Moderate	Moderately high

Patients who choose Georgia are mostly because surrogacy is legal and the laws are relatively stable, while costs are lower than in the US and Western Europe. However, it is important to note that since 2023, there have been discussions about surrogacy laws within Georgia. It is recommended to confirm the current legal status through professional channels before starting the process.

IV. Most Easily Overlooked Details (G)

In clinical and process coordination work, the following details are most frequently overlooked, directly impacting the smoothness of the cycle:

Validity of Test Reports: Infectious disease screenings (HIV, Hepatitis B, etc.) are typically valid for 3 months. Chromosome reports are valid for life. Semen analysis is recommended within 3 months. Before departure, be sure to check the validity of all reports to avoid needing to repeat them in Georgia.
Document Translation and Notarization: Passports, marriage certificates (if applicable), past medical records, and test reports need to be translated into English or Russian and notarized. Some Georgian institutions require translations to be issued by certified translation agencies.
Visa Type: Georgia offers visa-free or visa-on-arrival entry for some countries, but it is recommended to confirm visa requirements in advance for medical travel. If planning to stay for more than 30 days, a corresponding visa is required.
Medication Carrying: Ovulation induction medications are usually provided by the Georgian center, but some patients may need to use down-regulation medications domestically in advance. Carrying medications into the country requires a doctor's prescription and English instructions.
Insurance Coverage: Georgia's healthcare system typically requires international patients to pay out-of-pocket. It is recommended to purchase travel medical insurance that covers complications of assisted reproduction.

V. Most Common Pitfalls (H)

From frontline observations, the following three pitfalls are most common:

Insufficient Legal Contract Signing: In the surrogacy process, the surrogacy contract must clearly define the rights and obligations of both parties, embryo ownership, compensation standards, medical decision-making rights, etc. It is recommended to have a lawyer familiar with Georgian law review the contract and not directly use a template.
Payment Method Risks: Some agencies or centers require full payment in advance or transfer to personal accounts. Fees for legitimate fertility centers should be paid in stages and through corporate accounts. Verify the recipient's qualifications before payment.
Unrealistic Expectations for Embryo Quantity and Quality: Ovulation induction results for older patients or those with low ovarian reserve may not meet expectations at some Georgian centers. Before egg retrieval, discuss the "worst-case scenario" (e.g., no transferable embryos) with your doctor, including whether to accept egg donation or undergo a second egg retrieval to accumulate embryos.

VI. Actual Process and Timeline (I + J)

Below is a detailed timeline for a standard cycle, using "self-transfer" as an example (the surrogacy process requires an additional 4–8 weeks for surrogate evaluation and legal procedures):

Time Point	Action	Notes
4–6 weeks before departure	Complete all medical tests, document translation and notarization, purchase insurance, confirm visa	Prioritize key items like AMH, semen analysis, and chromosome tests
2–3 weeks before departure	Confirm medical records with Georgian center, pre-communicate the plan, book travel	Some centers require electronic submission of all reports in advance
Day 2–3 of menstruation	Arrive in Georgia, blood test + ultrasound to confirm baseline status, start ovulation induction	Ovulation induction medications used for approximately 10–14 days
Day 5–7 of ovulation induction	Monitor follicle growth every 1–2 days, adjust medication dosage	Trigger shot administered when follicle diameter reaches 18–20mm
36 hours after trigger shot	Egg retrieval surgery (IV sedation, approx. 15–20 minutes)	Can leave after resting 2–4 hours post-retrieval
3–6 days after egg retrieval	Embryo culture, optional PGT biopsy (takes 5–6 days)	PGT results require an additional 2–3 weeks
Embryo Transfer	Fresh embryo transfer (3–5 days post-retrieval) or frozen embryo transfer (subsequent cycle)	Frozen embryo transfer requires endometrial preparation (approx. 10–14 days)
10–14 days after transfer	Blood pregnancy test (β-hCG)	If positive, continue luteal phase support; if negative, discontinue medication

▎Time Reminder: If planning to undergo PGT genetic testing, the total cycle will be extended by 2–3 weeks. For patients with very low ovarian reserve, a longer stay in Georgia may be necessary for multiple egg retrievals to accumulate embryos. Confirm with the center in advance whether they offer a "cumulative cycle" plan.
        

VII. Frequently Asked Questions (Q)

Q1: My AMH is very low. Can I still do IVF in Georgia?

A: Yes, but you need to have realistic expectations. AMH below 0.5 ng/mL indicates severely diminished ovarian reserve, typically yielding 1–3 eggs per retrieval. Such patients are advised to use mild stimulation or natural cycle protocols and be prepared for the possibility of multiple retrievals. Some centers in Georgia have experience with poor responders, but aiming for "success on the first try" is not realistic.

Q2: Does the male partner need to go to Georgia?

A: If using fresh semen, the male partner needs to be present on the day of egg retrieval. If semen is frozen in advance, the male partner does not need to go, but freezing and transportation must be completed domestically. It is recommended to confirm the Georgian center's requirements for semen freezing and transportation in advance.

Q3: How much does assisted reproduction in Georgia cost?

A: Costs vary greatly depending on the plan. An IVF cycle for self-transfer (excluding surrogacy) is approximately $8,000–$15,000, including ovulation induction, egg retrieval, embryo culture, and transfer. The total cost for a surrogacy process typically ranges from $35,000–$55,000, including surrogate compensation, legal fees, and medical expenses. Specific costs are subject to the center's quotation; be sure to confirm whether it includes all medications and PGT costs.

Q4: How long do I need to rest in bed after embryo transfer?

A: You can resume normal activities after the transfer; prolonged bed rest is not necessary. It is recommended to rest for 1–2 days after the transfer, avoiding strenuous exercise, heavy lifting, and high-temperature environments (saunas, hot baths). Prolonged bed rest does not improve implantation rates and may increase the risk of blood clots.

Q5: Can embryos from Georgia be shipped back to my country?

A: Currently, Chinese law prohibits the import of embryos and gametes from abroad. If you plan to use the embryos domestically in the future, you need to understand the regulations of both countries in advance. Most patients choose to complete the entire process in Georgia or have their embryos cryopreserved and stored in a Georgian embryo bank.

VIII. Doctor's Perspective: Key Medical Quality Control Points in the Process (C)

From a reproductive doctor's perspective, the following three quality control points in the Georgian assisted reproduction process directly determine the success or failure of the cycle:

Individualized Ovulation Induction Protocol: Different ages, AMH levels, and past response histories require completely different protocols. Some Georgian centers tend to use standard long protocols, which may be less effective for poor responders. It is recommended to confirm the protocol logic with the doctor before departure to avoid a "one-size-fits-all" approach.
Laboratory Quality: Embryo culture has extremely high requirements for the laboratory environment, incubators, and air quality. Laboratory standards vary among different centers in Georgia. It is advisable to check whether the lab has hardware configurations such as real-time air quality monitoring, time-lapse incubators, and embryo scoring systems.
Luteal Phase Support Protocol: Luteal phase support after transfer is crucial for implantation rates. Common luteal phase support includes vaginal progesterone gel, oral dydrogesterone, or injectable progesterone. Medication practices in Georgian centers may differ from those domestically; confirm the protocol details before the transfer.

IX. Special Circumstances (N)

The following special circumstances require separate discussion:

Advanced Age (≥40 years): PGT-A (aneuploidy screening) is recommended as a priority to reduce the risk of implantation failure and miscarriage due to embryonic chromosomal abnormalities. Simultaneously, the uterine cavity environment needs to be assessed to rule out endometrial pathology.
Recurrent IVF Failure: It is necessary to investigate immune factors, coagulation abnormalities, chronic endometritis, embryonic chromosomal abnormalities, etc. Some centers in Georgia offer ERA (endometrial receptivity array) and EMMA/ALICE (endometrial microbiome testing), but this needs to be confirmed in advance.
Using Donor Eggs/Sperm: Georgia has formal egg and sperm banks. Donors are typically anonymous, but the scope of medical screening for egg donors (including genetic carrier screening) needs to be confirmed. Legally, the ownership of children born from donated eggs is determined by the surrogacy contract or law, requiring lawyer involvement.

⚠ Risk Reminder: Any assisted reproduction process carries medical risks and uncertainties. Georgia's medical regulatory system differs from China's, and patients have limited capacity to handle medical disputes. It is recommended before departure to: (1) purchase medical insurance covering complications of assisted reproduction; (2) keep all original and translated copies of medical documents; (3) sign a clear informed consent form with the center, confirming terms such as embryo disposition rights and the handling of surplus embryos. Not promising success rates and not guaranteeing a live birth are fundamental principles of medical ethics. Be wary of any promotion that guarantees "success."

X. Doctor's Advice: Next Steps

If you are considering assisted reproduction in Georgia, the following steps can serve as a reference:

Complete a full medical evaluation (AMH, sex hormones, semen analysis, chromosomes, infectious disease screening, uterine cavity assessment) to establish your medical baseline.
Organize all reports and contact 2–3 Georgian fertility centers for preliminary communication to obtain initial plans and cost details.
Confirm legal and visa requirements, especially the current status of laws related to surrogacy.
Create a timeline, including test validity periods, document processing, travel arrangements, and estimated length of stay.
Set realistic expectations: Discuss "best-case" and "worst-case" scenarios with your doctor, including the number of eggs retrieved, number of embryos, chances of transfer, and backup plans (e.g., egg donation, second egg retrieval).

This article is edited by the Reproductive Medicine Knowledge Base, based on standard clinical procedures and industry consensus, and does not constitute medical advice. Please consult a licensed reproductive doctor for specific treatment plans.

Article text ends